IN-HOSPITAL OUTCOMES OF MYOCARDIAL REVASCULARIZATION USING AN I-CONDUIT AND NO-TOUCH SAPHENOUS VEIN GRAFTING: RESULTS OF A RANDOMIZED CONTROLLED TRIAL
https://doi.org/10.17802/2306-1278-2026-15-4-65-76
Abstract
Highlights
● In this prospective randomized study (n = 106), no statistically significant differences were observed in the incidence of MACCE, in-hospital mortality, or conduit harvest-site complications between the I-graft and the free venous graft using the no-touch technique.
● The use of a no-touch saphenous vein conduit as part of an I-graft does not increase intraoperative risk or worsen early postoperative outcomes compared with a free venous graft configuration.
● The no-touch technique does not limit the choice of graft configuration and demonstrates comparable safety and reproducibility in the in-hospital period.
Aim. To evaluate in-hospital outcomes of myocardial revascularization using an I-conduit versus a no-touch saphenous vein graft in a randomized controlled trial.
Methods. This prospective randomized study included 106 patients with coronary artery disease who underwent coronary artery bypass grafting between January 2023 and December 2024. Patients were randomized using sealed envelopes into two groups: the first group underwent revascularization with a no-touch saphenous vein conduit configured as an I-composite graft (n = 53); the second group received revascularization with the same no-touch conduit but with a proximal anastomosis to the ascending aorta (n = 53). In-hospital outcomes included the incidence of major adverse cardiac and cerebrovascular events (MACCE), conduit harvest-site complications, and mortality.
Results. The groups were comparable in demographic, clinical, and surgical characteristics. No statistically significant differences were observed in the in-hospital incidence of MACCE (1.89% vs 0%; p > 0,99), mortality (1.89% vs 0%; p > 0.99), harvest-site complications (edema: 11.32% vs 16.98%; p = 0.58), or length of hospital stay (12.5 ± 9.2 vs 11.7 ± 4.0 days; p = 0.95).
Conclusion. This prospective randomized study demonstrated comparable safety and efficacy of the no-touch technique when used as an I-graft or as a free venous graft in coronary artery bypass surgery. No significant differences were found in MACCE, harvest-site complications, or in-hospital mortality. Both approaches showed similarly favorable early postoperative outcomes. Long-term advantages of the I-graft configuration require further investigation.
About the Authors
Alexander G. MakaevRussian Federation
Junior Researcher, Research Department of Aortic, Coronary and Peripheral Artery Surgery, Institute of Circulation Pathology, Cardiovascular Surgeon, Cardiac Surgery Department No. 2, Postgraduate Student (3rd year), specialty “Cardiovascular Surgery,” National Medical Research Center named after Academician E.N. Meshalkin, Novosibirsk, Russian Federation
Dmitry S. Khvan
Russian Federation
PhD, MD, Senior Researcher, Research Department of Aortic, Coronary and Peripheral Artery Surgery, Institute of Circulation Pathology, Cardiovascular Surgeon, Cardiac Surgery Department No. 2, National Medical Research Center named after Academician E.N. Meshalkin, Novosibirsk, Russian Federation
Dmitry A. Sirota
Russian Federation
PhD, MD, Head of the Research Department of Aortic, Coronary and Peripheral Artery Surgery, Institute of Circulation Pathology, Cardiovascular Surgeon, Cardiac Surgery Department No. 2, National Medical Research Center named after Academician E.N. Meshalkin, Novosibirsk, Russian Federation; Associate Professor at the Department of Cardiovascular Surgery, Faculty of Advanced Training and Professional Retraining of Doctors, Department of Postgraduate Education, Novosibirsk State Medical University, Novosibirsk, Russian Federation
Maxim O. Zhulkov
Russian Federation
PhD, MD, Researcher, Research Department of Aortic, Coronary and Peripheral Artery Surgery, Institute of Circulation Pathology, Cardiovascular Surgeon, Cardiac Surgery Department No. 2, National Medical Research Center named after Academician E.N. Meshalkin, Novosibirsk, Russian Federation
Khava A. Agaeva
Russian Federation
Cardiovascular Surgeon, Cardiac Surgery Department No. 2, National Medical Research Center named after Academician E.N. Meshalkin, Novosibirsk, Russian Federation
Alexander V. Bogachev-Prokofiev
Russian Federation
PhD, MD, Director of the Institute of Circulation Pathology, Cardiovascular Surgeon, Cardiac Surgery Department No. 3, National Medical Research Center named after Academician E.N. Meshalkin, Novosibirsk, Russian Federation
Aleksei A. Semagin
Russian Federation
Cardiovascular Surgeon, Federal Center for Cardiovascular Surgery (Chelyabinsk), Chelyabinsk, Russian Federation
Vladislav V. Aminov
Russian Federation
Head of Cardiac Surgery Department No. 2, Federal Center for Cardiovascular Surgery (Chelyabinsk), Chelyabinsk, Russian Federation
Vladlen V. Bazylev
Russian Federation
PhD, MD, Professor, Chief Physician, Federal Center for Cardiovascular Surgery (Penza), Penza, Russian Federation
Dmitry S. Tungusov
Russian Federation
PhD, MD, Deputy Chief Physician for Surgery, Federal Center for Cardiovascular Surgery (Penza), Penza, Russian Federation
Alexander S. Zotov
Russian Federation
PhD, MD, Head of Department, Cardiovascular Surgeon, Federal Scientific and Clinical Center for Specialized Types of Medical Care and Medical Technologies of the Federal Medical and Biological Agency of Russia, Moscow, Russian Federation
Emil R. Sakharov
Russian Federation
Cardiovascular Surgeon, Federal Scientific and Clinical Center for Specialized Types of Medical Care and Medical Technologies of the Federal Medical and Biological Agency of Russia, Moscow, Russian Federation
Oleg O. Shelest
Russian Federation
Cardiovascular Surgeon, Federal Scientific and Clinical Center for Specialized Types of Medical Care and Medical Technologies of the Federal Medical and Biological Agency of Russia, Moscow, Russian Federation
Andrey N. Semchenko
Russian Federation
PhD, MD, Cardiovascular Surgeon, Federal Center for Cardiovascular Surgery (Khabarovsk), Khabarovsk, Russian Federation
Vladislav A. Kovlyakov
Russian Federation
PhD, MD, Cardiovascular Surgeon, Federal Center for Cardiovascular Surgery (Khabarovsk), Khabarovsk, Russian Federation
Evgeny V. Rosseikin
Russian Federation
PhD, MD, Chief Physician, Cardiovascular Surgeon, Federal Center for Cardiovascular Surgery (Khabarovsk), Khabarovsk, Russian Federation
References
1. Harskamp RE, Lopes RD, Baisden CE, De Winter RJ, Alexander JH. Saphenous vein graft failure after coronary artery bypass surgery: pathophysiology, management, and future directions. Ann Surg. 2013;257(5):824-833. DOI: 10.1097/SLA.0b013e318288c38d
2. Fitzgibbon GM, Kafka HP, Leach AJ, Keon WJ, Hooper GD, Burton JR. Coronary bypass graft fate and patient outcome: angiographic follow-up of 5,065 grafts related to survival and reoperation in 1,388 patients during 25 years. J Am Coll Cardiol. 1996;28(3):616-626. DOI: 10.1016/0735-1097(96)00206-9
3. Samano N, Geijer H, Liden M, Fremes S, Bodin L, Souza D. The no-touch saphenous vein for coronary artery bypass grafting maintains patency, after 16 years, comparable to the left internal thoracic artery: a randomized trial. J Thorac Cardiovasc Surg. 2015;150(4):880-888. DOI: 10.1016/j.jtcvs.2015.07.027
4. Gaudino M, Antoniades C, Benedetto U, Deb S, Di Franco A, Di Giammarco G, et al. Mechanisms, consequences, and prevention of coronary graft failure. Circulation. 2017;136(18):1749-1764. DOI: 10.1161/CIRCULATIONAHA.117.027597
5. Souza DSR, Christofferson RHB, Bomfim V, Filbey D. No-touch technique using saphenous vein harvested with its surrounding tissue for coronary artery bypass grafting maintains an intact endothelium. Scand Cardiovasc J. 1999;33(6):323-329. DOI: 10.1080/14017439950141362
6. Deng MX, Li Z, Vervoort D, Evan RN, Fremes SE. Graft patency of no-touch versus conventionally harvested saphenous vein conduits in coronary artery bypass grafting: a frequentist and Bayesian meta-analysis of randomized trials. JTCVS Open. 2025;24. DOI: 10.1016/j.xjon.2025.02.007
7. Bazylev VV, Tungusov DS, Mikulyak AI, Senzhapov IY. Comparison of the results of right coronary artery bypass grafting using combined I-grafts and composite T-grafts in patients with recurrent angina pectoris. Grudnaya i serdechno-sosudistaya khirurgiya. 2021;63(5):418-423. (In Russ.). DOI: 10.24022/0236-2791-2021-63-5-418-423
8. Sabetov AK, Sirota DA, Khvan DS, Zhulkov MO, Chernyavskiy AM. Arterial myocardial revascularization using Y-composite grafts and in situ internal thoracic artery conduits: immediate results. Patologiya krovoobrashcheniya i kardiokhirurgiya. 2020;24(4):63-71. (In Russ.). DOI: 10.21688/1681-3472-2020-4-63-71
9. Calafiore AM, Prapas S, Condello I, Katsavrias K, Nasso G, Gaudino M. The saphenous vein graft: can a frog become a princess? Medicina (Kaunas). 2024;60(12):1915. DOI: 10.3390/medicina60121915
10. Kim MS, Hwang HY, Kim JS, Oh SJ, Jang MJ, Kim KB. Saphenous vein versus right internal thoracic artery as a Y-composite graft: five-year angiographic and clinical results of a randomized trial. J Thorac Cardiovasc Surg. 2018;156(4):1424-1433.e1. DOI: 10.1016/j.jtcvs.2018.04.123
11. Hwang HY, Lee KH, Han JW, Kim KB. Equivalency of saphenous vein and arterial composite grafts: 5-year angiography and midterm clinical follow-up. Ann Thorac Surg. 2016;102(2):580-588. DOI: 10.1016/j.athoracsur.2016.02.017
12. Benussi B, Savini C, Di Eusanio M, et al. Clinical Validation of a Coronary Surgery Technique That Minimizes Aortic Manipulation. Ann Thorac Surg. 2019;107(4):1166-1173. DOI: 10.1016/j.athoracsur.2018.09.063
13. Bazylev VV, Nemchenko EV, Pavlov AA, Karnakhin VA. Indices of intraoperative flowmetry, determining patency of grafts in the remote period after revascularization of the right coronary artery. Angiologiya i sosudistaya khirurgiya. 2016;22(2):60-66. (In Russ.). PMID: 27336335
14. Tsuneyoshi H, Setozaki S, Katayama H, Wada T, Shimomura S, Takeuchi A, et al. Early and midterm outcomes of no-touch saphenous vein grafts in Japanese institutions. Braz J Cardiovasc Surg. 2022;37(Special Issue 1):42-48. DOI: 10.21470/1678-9741-2022-0121
15. Rosseikin EV, Bazylev VV, Kobzev EE, Voevodin AB, Batrakov PA, Nachkebia BR, et al. Immediate results of bypass grafting of the territory of the right coronary artery using the "Penza coronary technology". Angiologiya i sosudistaya khirurgiya. 2019;25(2):137-147. (In Russ.). DOI: 10.33529/ANGIO2019221
16. Ahmed SR, Johansson BL, Karlsson MG, Souza DSR, Dashwood MR, Loesch A. Human saphenous vein and coronary bypass surgery: ultrastructural aspects of conventional and no-touch vein graft preparations. Histol Histopathol. 2004;19(2):421-433. DOI: 10.14670/HH-19.421
17. Mannion JD, Marelli D, Brandt T, Stallings M, Cirks J, Dreifaldt M, et al. No-touch versus endo vein harvest: early patency on symptom-directed catheterization and harvest site complications. Innovations (Phila). 2014;9(4):306-311. DOI: 10.1097/IMI.0000000000000084
18. Zhao TY, Wang BJ, Liu J, Liu C, Bu JQ, Liu Y, et al. Improved technique reduces lower limb complications after the traditional no-touch technique for vein graft harvesting: a single-center retrospective historical controlled study. J Multidiscip Healthc. 2024;17:5435-5444. DOI: 10.2147/JMDH.S492144
Review
For citations:
Makaev A.G., Khvan D.S., Sirota D.A., Zhulkov M.O., Agaeva Kh.A., Bogachev-Prokofiev A.V., Semagin A.A., Aminov V.V., Bazylev V.V., Tungusov D.S., Zotov A.S., Sakharov E.R., Shelest O.O., Semchenko A.N., Kovlyakov V.A., Rosseikin E.V. IN-HOSPITAL OUTCOMES OF MYOCARDIAL REVASCULARIZATION USING AN I-CONDUIT AND NO-TOUCH SAPHENOUS VEIN GRAFTING: RESULTS OF A RANDOMIZED CONTROLLED TRIAL. Complex Issues of Cardiovascular Diseases. 2026;15(4):65-76. (In Russ.) https://doi.org/10.17802/2306-1278-2026-15-4-65-76
JATS XML

































